nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—DRD3—attention deficit hyperactivity disorder	0.344	0.449	CbGaD
Pimozide—DRD2—attention deficit hyperactivity disorder	0.238	0.311	CbGaD
Pimozide—HTR2A—attention deficit hyperactivity disorder	0.184	0.24	CbGaD
Pimozide—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.0045	0.0661	CbGeAlD
Pimozide—CALM1—autonomic nervous system—attention deficit hyperactivity disorder	0.00393	0.0577	CbGeAlD
Pimozide—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00239	0.0351	CbGeAlD
Pimozide—HTR6—forebrain—attention deficit hyperactivity disorder	0.00192	0.0282	CbGeAlD
Pimozide—OPRK1—forebrain—attention deficit hyperactivity disorder	0.00178	0.0261	CbGeAlD
Pimozide—CACNA1G—nervous system—attention deficit hyperactivity disorder	0.00152	0.0223	CbGeAlD
Pimozide—CACNA1G—central nervous system—attention deficit hyperactivity disorder	0.00147	0.0215	CbGeAlD
Pimozide—CACNA1G—cerebellum—attention deficit hyperactivity disorder	0.00143	0.021	CbGeAlD
Pimozide—OPRM1—forebrain—attention deficit hyperactivity disorder	0.00127	0.0186	CbGeAlD
Pimozide—CACNA1G—brain—attention deficit hyperactivity disorder	0.00116	0.0171	CbGeAlD
Pimozide—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00115	0.0169	CbGeAlD
Pimozide—DRD3—nervous system—attention deficit hyperactivity disorder	0.00109	0.0159	CbGeAlD
Pimozide—DRD3—central nervous system—attention deficit hyperactivity disorder	0.00104	0.0153	CbGeAlD
Pimozide—HTR6—nervous system—attention deficit hyperactivity disorder	0.00104	0.0153	CbGeAlD
Pimozide—HTR6—central nervous system—attention deficit hyperactivity disorder	0.00101	0.0148	CbGeAlD
Pimozide—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000975	0.0143	CbGeAlD
Pimozide—OPRK1—nervous system—attention deficit hyperactivity disorder	0.000967	0.0142	CbGeAlD
Pimozide—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000936	0.0137	CbGeAlD
Pimozide—OPRK1—central nervous system—attention deficit hyperactivity disorder	0.000931	0.0137	CbGeAlD
Pimozide—CALM2—forebrain—attention deficit hyperactivity disorder	0.00092	0.0135	CbGeAlD
Pimozide—CALM1—forebrain—attention deficit hyperactivity disorder	0.000915	0.0134	CbGeAlD
Pimozide—OPRK1—cerebellum—attention deficit hyperactivity disorder	0.00091	0.0134	CbGeAlD
Pimozide—DRD2—forebrain—attention deficit hyperactivity disorder	0.000846	0.0124	CbGeAlD
Pimozide—OPRM1—midbrain—attention deficit hyperactivity disorder	0.000837	0.0123	CbGeAlD
Pimozide—KCNH2—forebrain—attention deficit hyperactivity disorder	0.000833	0.0122	CbGeAlD
Pimozide—DRD3—brain—attention deficit hyperactivity disorder	0.000829	0.0122	CbGeAlD
Pimozide—Sertindole—DRD4—attention deficit hyperactivity disorder	0.000816	0.101	CrCbGaD
Pimozide—HTR6—brain—attention deficit hyperactivity disorder	0.000798	0.0117	CbGeAlD
Pimozide—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000791	0.0116	CbGeAlD
Pimozide—CALM2—cardiovascular system—attention deficit hyperactivity disorder	0.000778	0.0114	CbGeAlD
Pimozide—CALM1—cardiovascular system—attention deficit hyperactivity disorder	0.000774	0.0114	CbGeAlD
Pimozide—CALM3—midbrain—attention deficit hyperactivity disorder	0.000773	0.0113	CbGeAlD
Pimozide—Droperidol—DRD2—attention deficit hyperactivity disorder	0.000755	0.0936	CrCbGaD
Pimozide—OPRK1—brain—attention deficit hyperactivity disorder	0.000739	0.0108	CbGeAlD
Pimozide—Sertindole—HTR1B—attention deficit hyperactivity disorder	0.000725	0.0898	CrCbGaD
Pimozide—KCNH2—cardiovascular system—attention deficit hyperactivity disorder	0.000704	0.0103	CbGeAlD
Pimozide—Sertindole—DRD3—attention deficit hyperactivity disorder	0.000704	0.0872	CrCbGaD
Pimozide—OPRM1—nervous system—attention deficit hyperactivity disorder	0.000688	0.0101	CbGeAlD
Pimozide—HRH1—forebrain—attention deficit hyperactivity disorder	0.000668	0.0098	CbGeAlD
Pimozide—OPRM1—central nervous system—attention deficit hyperactivity disorder	0.000662	0.00972	CbGeAlD
Pimozide—Sertindole—ADRA2A—attention deficit hyperactivity disorder	0.000642	0.0795	CrCbGaD
Pimozide—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000626	0.00919	CbGeAlD
Pimozide—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000618	0.00907	CbGeAlD
Pimozide—CALM2—midbrain—attention deficit hyperactivity disorder	0.000607	0.00891	CbGeAlD
Pimozide—CALM1—midbrain—attention deficit hyperactivity disorder	0.000605	0.00887	CbGeAlD
Pimozide—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000603	0.00885	CbGeAlD
Pimozide—CALM3—cerebellum—attention deficit hyperactivity disorder	0.000598	0.00878	CbGeAlD
Pimozide—Droperidol—HTR2A—attention deficit hyperactivity disorder	0.000584	0.0723	CrCbGaD
Pimozide—DRD2—midbrain—attention deficit hyperactivity disorder	0.000558	0.00819	CbGeAlD
Pimozide—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000558	0.00818	CbGeAlD
Pimozide—KCNH2—midbrain—attention deficit hyperactivity disorder	0.00055	0.00807	CbGeAlD
Pimozide—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000543	0.00796	CbGeAlD
Pimozide—OPRM1—brain—attention deficit hyperactivity disorder	0.000526	0.00772	CbGeAlD
Pimozide—Fluspirilene—ADRA2A—attention deficit hyperactivity disorder	0.000523	0.0648	CrCbGaD
Pimozide—Domperidone—DRD3—attention deficit hyperactivity disorder	0.000513	0.0636	CrCbGaD
Pimozide—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000508	0.00746	CbGeAlD
Pimozide—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000508	0.00746	CbGeAlD
Pimozide—CALM2—nervous system—attention deficit hyperactivity disorder	0.000499	0.00733	CbGeAlD
Pimozide—CALM1—nervous system—attention deficit hyperactivity disorder	0.000497	0.00729	CbGeAlD
Pimozide—Sertindole—SLC6A4—attention deficit hyperactivity disorder	0.00049	0.0606	CrCbGaD
Pimozide—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000489	0.00718	CbGeAlD
Pimozide—Sertindole—DRD2—attention deficit hyperactivity disorder	0.000487	0.0603	CrCbGaD
Pimozide—CALM3—brain—attention deficit hyperactivity disorder	0.000486	0.00713	CbGeAlD
Pimozide—CALM2—central nervous system—attention deficit hyperactivity disorder	0.000481	0.00705	CbGeAlD
Pimozide—CHRM2—brain—attention deficit hyperactivity disorder	0.000479	0.00702	CbGeAlD
Pimozide—CALM1—central nervous system—attention deficit hyperactivity disorder	0.000478	0.00702	CbGeAlD
Pimozide—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000478	0.00702	CbGeAlD
Pimozide—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000472	0.00692	CbGeAlD
Pimozide—CALM2—cerebellum—attention deficit hyperactivity disorder	0.00047	0.00689	CbGeAlD
Pimozide—CALM1—cerebellum—attention deficit hyperactivity disorder	0.000468	0.00686	CbGeAlD
Pimozide—DRD2—nervous system—attention deficit hyperactivity disorder	0.000459	0.00674	CbGeAlD
Pimozide—KCNH2—nervous system—attention deficit hyperactivity disorder	0.000452	0.00664	CbGeAlD
Pimozide—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000442	0.00649	CbGeAlD
Pimozide—KCNH2—central nervous system—attention deficit hyperactivity disorder	0.000435	0.00639	CbGeAlD
Pimozide—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000432	0.00634	CbGeAlD
Pimozide—KCNH2—cerebellum—attention deficit hyperactivity disorder	0.000426	0.00625	CbGeAlD
Pimozide—Fluspirilene—SLC6A4—attention deficit hyperactivity disorder	0.000399	0.0494	CrCbGaD
Pimozide—Fluspirilene—DRD2—attention deficit hyperactivity disorder	0.000397	0.0492	CrCbGaD
Pimozide—HTR1A—brain—attention deficit hyperactivity disorder	0.000388	0.0057	CbGeAlD
Pimozide—CALM2—brain—attention deficit hyperactivity disorder	0.000382	0.0056	CbGeAlD
Pimozide—CALM1—brain—attention deficit hyperactivity disorder	0.00038	0.00557	CbGeAlD
Pimozide—Sertindole—HTR2A—attention deficit hyperactivity disorder	0.000376	0.0466	CrCbGaD
Pimozide—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000368	0.0054	CbGeAlD
Pimozide—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000365	0.00536	CbGeAlD
Pimozide—HRH1—nervous system—attention deficit hyperactivity disorder	0.000362	0.00532	CbGeAlD
Pimozide—Domperidone—DRD2—attention deficit hyperactivity disorder	0.000355	0.044	CrCbGaD
Pimozide—DRD2—brain—attention deficit hyperactivity disorder	0.000351	0.00515	CbGeAlD
Pimozide—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000349	0.00512	CbGeAlD
Pimozide—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000348	0.00511	CbGeAlD
Pimozide—KCNH2—brain—attention deficit hyperactivity disorder	0.000346	0.00507	CbGeAlD
Pimozide—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000335	0.00492	CbGeAlD
Pimozide—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000328	0.00481	CbGeAlD
Pimozide—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000309	0.00454	CbGeAlD
Pimozide—Fluspirilene—HTR2A—attention deficit hyperactivity disorder	0.000307	0.038	CrCbGaD
Pimozide—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000303	0.00444	CbGeAlD
Pimozide—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000291	0.00428	CbGeAlD
Pimozide—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000285	0.00418	CbGeAlD
Pimozide—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00028	0.00411	CbGeAlD
Pimozide—HRH1—brain—attention deficit hyperactivity disorder	0.000277	0.00407	CbGeAlD
Pimozide—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000276	0.00405	CbGeAlD
Pimozide—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00027	0.00396	CbGeAlD
Pimozide—CYP2E1—brain—attention deficit hyperactivity disorder	0.000266	0.00391	CbGeAlD
Pimozide—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000266	0.0039	CbGeAlD
Pimozide—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00026	0.00381	CbGeAlD
Pimozide—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000241	0.00354	CbGeAlD
Pimozide—HTR2A—brain—attention deficit hyperactivity disorder	0.000231	0.0034	CbGeAlD
Pimozide—CYP2D6—brain—attention deficit hyperactivity disorder	0.000211	0.00309	CbGeAlD
Pimozide—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000198	0.00291	CbGeAlD
Pimozide—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000191	0.0028	CbGeAlD
Pimozide—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000187	0.00274	CbGeAlD
Pimozide—ABCB1—brain—attention deficit hyperactivity disorder	0.000152	0.00223	CbGeAlD
Pimozide—CALM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.97e-05	0.000125	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.96e-05	0.000124	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.96e-05	0.000124	CbGpPWpGaD
Pimozide—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	1.94e-05	0.000123	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.94e-05	0.000123	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.93e-05	0.000122	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.93e-05	0.000122	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.93e-05	0.000122	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.91e-05	0.000121	CbGpPWpGaD
Pimozide—CALM3—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	1.9e-05	0.000121	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.9e-05	0.00012	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.9e-05	0.00012	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.9e-05	0.00012	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.89e-05	0.00012	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.89e-05	0.000119	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.87e-05	0.000118	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.87e-05	0.000118	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.86e-05	0.000118	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.85e-05	0.000117	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.85e-05	0.000117	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.84e-05	0.000117	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.84e-05	0.000117	CbGpPWpGaD
Pimozide—CALM1—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	1.84e-05	0.000117	CbGpPWpGaD
Pimozide—CALM2—Signaling by WNT in cancer—EP300—attention deficit hyperactivity disorder	1.84e-05	0.000117	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.82e-05	0.000115	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.81e-05	0.000115	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.8e-05	0.000114	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.8e-05	0.000114	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.79e-05	0.000113	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.79e-05	0.000113	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.79e-05	0.000113	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	1.78e-05	0.000113	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.78e-05	0.000113	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.76e-05	0.000112	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.76e-05	0.000111	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.76e-05	0.000111	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.74e-05	0.00011	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.73e-05	0.00011	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.73e-05	0.00011	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.73e-05	0.00011	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.72e-05	0.000109	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.71e-05	0.000108	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.7e-05	0.000107	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.7e-05	0.000107	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.7e-05	0.000107	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.69e-05	0.000107	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	1.69e-05	0.000107	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.69e-05	0.000107	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.69e-05	0.000107	CbGpPWpGaD
Pimozide—CALM3—Metabolism—TPH2—attention deficit hyperactivity disorder	1.68e-05	0.000107	CbGpPWpGaD
Pimozide—CALM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.68e-05	0.000107	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.67e-05	0.000106	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.67e-05	0.000106	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.67e-05	0.000106	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.67e-05	0.000105	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	1.66e-05	0.000105	CbGpPWpGaD
Pimozide—CALM3—Metabolism—DPYD—attention deficit hyperactivity disorder	1.66e-05	0.000105	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.64e-05	0.000104	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Pimozide—CALM2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Pimozide—CALM1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.63e-05	0.000103	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.62e-05	0.000102	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.62e-05	0.000102	CbGpPWpGaD
Pimozide—CALM3—Disease—SNAP25—attention deficit hyperactivity disorder	1.61e-05	0.000102	CbGpPWpGaD
Pimozide—CALM2—Metabolism—DPYD—attention deficit hyperactivity disorder	1.6e-05	0.000102	CbGpPWpGaD
Pimozide—CALM1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.6e-05	0.000102	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.59e-05	0.000101	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.58e-05	9.99e-05	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.58e-05	9.98e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.57e-05	9.94e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.57e-05	9.94e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—SNAP25—attention deficit hyperactivity disorder	1.56e-05	9.85e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—SNAP25—attention deficit hyperactivity disorder	1.56e-05	9.85e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.55e-05	9.82e-05	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.55e-05	9.8e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.55e-05	9.8e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.54e-05	9.76e-05	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.52e-05	9.64e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.52e-05	9.63e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.52e-05	9.61e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by Wnt—EP300—attention deficit hyperactivity disorder	1.52e-05	9.61e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.49e-05	9.47e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.49e-05	9.44e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.49e-05	9.44e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.48e-05	9.39e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.48e-05	9.35e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.48e-05	9.35e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.46e-05	9.24e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.46e-05	9.22e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.43e-05	9.07e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.43e-05	9.07e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	1.42e-05	8.98e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	1.41e-05	8.92e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.41e-05	8.9e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.39e-05	8.77e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.38e-05	8.76e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.38e-05	8.73e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.38e-05	8.71e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.36e-05	8.59e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.36e-05	8.58e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.35e-05	8.57e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.35e-05	8.56e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.35e-05	8.53e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.34e-05	8.49e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.34e-05	8.49e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.34e-05	8.45e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.33e-05	8.43e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.32e-05	8.36e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.31e-05	8.32e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.31e-05	8.31e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.31e-05	8.3e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.31e-05	8.28e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.31e-05	8.28e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.3e-05	8.25e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.3e-05	8.25e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.3e-05	8.24e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.3e-05	8.21e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	8.18e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	8.17e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.29e-05	8.17e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	8.16e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	8.15e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.29e-05	8.15e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.28e-05	8.12e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.28e-05	8.08e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.28e-05	8.08e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.28e-05	8.08e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.27e-05	8.06e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.27e-05	8.03e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.26e-05	7.95e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.25e-05	7.93e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	7.85e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.24e-05	7.85e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.21e-05	7.67e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.2e-05	7.62e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.2e-05	7.62e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.2e-05	7.58e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.19e-05	7.52e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.19e-05	7.51e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.18e-05	7.49e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.17e-05	7.42e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.17e-05	7.42e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.17e-05	7.4e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.17e-05	7.39e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.17e-05	7.39e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.14e-05	7.22e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.16e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.13e-05	7.16e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.13e-05	7.13e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.12e-05	7.07e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.11e-05	7e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.1e-05	6.97e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.09e-05	6.91e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.09e-05	6.9e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.09e-05	6.9e-05	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—EP300—attention deficit hyperactivity disorder	1.08e-05	6.84e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.07e-05	6.79e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.06e-05	6.7e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.06e-05	6.68e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.06e-05	6.68e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.05e-05	6.62e-05	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—EP300—attention deficit hyperactivity disorder	1.04e-05	6.61e-05	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—EP300—attention deficit hyperactivity disorder	1.04e-05	6.61e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.57e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.04e-05	6.57e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	1.03e-05	6.5e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	1.03e-05	6.49e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	6.49e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.02e-05	6.49e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.02e-05	6.46e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—COMT—attention deficit hyperactivity disorder	1.02e-05	6.46e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.02e-05	6.46e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.02e-05	6.45e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.02e-05	6.45e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	1.02e-05	6.44e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—MAOA—attention deficit hyperactivity disorder	1.01e-05	6.42e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1e-05	6.35e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.95e-06	6.3e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—COMT—attention deficit hyperactivity disorder	9.87e-06	6.25e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—COMT—attention deficit hyperactivity disorder	9.87e-06	6.25e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.86e-06	6.25e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.8e-06	6.21e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—MAOA—attention deficit hyperactivity disorder	9.8e-06	6.21e-05	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—EP300—attention deficit hyperactivity disorder	9.72e-06	6.15e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.72e-06	6.15e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.63e-06	6.1e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.62e-06	6.09e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.54e-06	6.04e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.54e-06	6.04e-05	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—EP300—attention deficit hyperactivity disorder	9.4e-06	5.95e-05	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—EP300—attention deficit hyperactivity disorder	9.4e-06	5.95e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.32e-06	5.9e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.16e-06	5.8e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.46e-06	5.36e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.3e-06	5.26e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.17e-06	5.17e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.15e-06	5.16e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	7.92e-06	5.02e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	7.87e-06	4.98e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.87e-06	4.98e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.87e-06	4.98e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.76e-06	4.91e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.74e-06	4.9e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	7.73e-06	4.9e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.68e-06	4.86e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.63e-06	4.83e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	7.29e-06	4.62e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.24e-06	4.58e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.19e-06	4.56e-05	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7e-06	4.43e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.91e-06	4.37e-05	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.89e-06	4.37e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.68e-06	4.23e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.68e-06	4.23e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.29e-06	3.98e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	6.17e-06	3.91e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	6.13e-06	3.88e-05	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	6.08e-06	3.85e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.99e-06	3.79e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.95e-06	3.77e-05	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.91e-06	3.74e-05	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.86e-06	3.71e-05	CbGpPWpGaD
Pimozide—CALM3—Immune System—EP300—attention deficit hyperactivity disorder	5.66e-06	3.58e-05	CbGpPWpGaD
Pimozide—CALM2—Immune System—EP300—attention deficit hyperactivity disorder	5.48e-06	3.47e-05	CbGpPWpGaD
Pimozide—CALM1—Immune System—EP300—attention deficit hyperactivity disorder	5.48e-06	3.47e-05	CbGpPWpGaD
Pimozide—CALM3—Disease—EP300—attention deficit hyperactivity disorder	5.23e-06	3.31e-05	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.1e-06	3.23e-05	CbGpPWpGaD
Pimozide—CALM2—Disease—EP300—attention deficit hyperactivity disorder	5.06e-06	3.2e-05	CbGpPWpGaD
Pimozide—CALM1—Disease—EP300—attention deficit hyperactivity disorder	5.06e-06	3.2e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.77e-06	3.02e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.73e-06	3e-05	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.48e-06	2.84e-05	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.41e-06	2.79e-05	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	4.4e-06	2.79e-05	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.4e-06	2.79e-05	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	4.4e-06	2.78e-05	CbGpPWpGaD
Pimozide—CALM3—Metabolism—EP300—attention deficit hyperactivity disorder	4.38e-06	2.77e-05	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.33e-06	2.74e-05	CbGpPWpGaD
Pimozide—CALM1—Metabolism—EP300—attention deficit hyperactivity disorder	4.23e-06	2.68e-05	CbGpPWpGaD
Pimozide—CALM2—Metabolism—EP300—attention deficit hyperactivity disorder	4.23e-06	2.68e-05	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.66e-06	2.32e-05	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.54e-06	2.24e-05	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.54e-06	2.24e-05	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	3.4e-06	2.15e-05	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.32e-06	2.1e-05	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	3.13e-06	1.98e-05	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.65e-06	1.68e-05	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.04e-06	1.29e-05	CbGpPWpGaD
